To the best of our knowledge, this is the first study to demonstrate a robust correlation between elevated Ki67 expression, low PR levels, and HER2 overexpression, which are indicative of aggressive DCIS phenotypes. This evidence concerns the gene MKI67 and ductal breast carcinoma in situ.